Position in GILD
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,549,812
-$2,345,022 QoQ
Shares Held
12,267
-56.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#912
of 2,266 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Monument Capital Management holds $17,122,223 across 11 Drug Manufacturers - General names. GILD ranks #5 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
18,097 | $4,596,095 | |
| 2 | LLY |
ELI LILLY & Co
|
2,528 | $3,032,159 | |
| 3 | MRK |
Merck & Co., Inc.
|
22,665 | $2,912,452 | |
| 4 | ABBV |
AbbVie Inc.
|
6,503 | $1,636,414 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
12,267 | $1,549,812 | |
| 6 | AMGN |
Amgen Inc
|
2,614 | $946,581 | |
| 7 | NVS |
Novartis AG
|
5,076 | $795,510 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,867 | $741,396 |
All Filings in GILD
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,549,812 | 12,267 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $3,894,834 | 27,946 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,693,075 | 13,794 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,089,354 | 9,814 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,024,660 | 9,242 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $913,207 | 8,150 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $660,814 | 7,154 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $514,190 | 6,133 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $333,924 | 4,867 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $709,939 | 9,692 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $887,626 | 10,957 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $737,184 | 9,837 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $793,281 | 10,293 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $912,835 | 11,002 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $817,292 | 9,520 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $497,221 | 8,060 | Shares | Sole | 2022-11-07 | |
| No filing history on record for this holder in this stock. | ||||||